Results 41 to 50 of about 640 (208)

PROTOCOL: Mass deworming for improving health and cognition of children in endemic helminth areas: a systematic review and individual participant data network meta‐analysis

open access: yes, 2018
Campbell Systematic Reviews, Volume 14, Issue 1, Page 1-46, 2018.
Vivian Welch   +15 more
wiley   +1 more source

PROTOCOL: Interventions for improving learning outcomes and access to education in low‐ and middle‐income countries: a systematic review

open access: yes, 2017
Campbell Systematic Reviews, Volume 13, Issue 1, Page 1-82, 2017.
Birte Snilstveit   +8 more
wiley   +1 more source

In vivo and In vitro of Arctiin Schistosomicidal Activity

open access: yesClinical and Experimental Pharmacology, 2017
Human schistosomiasis, caused by trematode worms of the genus Schistosoma, is one of the most significant neglected tropical diseases, affecting more 200 million individuals worldwide and praziquantel is the only available drug to treat this neglected disease.
Marconato Dg   +12 more
openaire   +2 more sources

PROTOCOL: Deworming and adjuvant interventions for improving the developmental health and well‐being of children in low‐and middle‐income countries: a systematic review and network meta‐analysis

open access: yes, 2013
Campbell Systematic Reviews, Volume 9, Issue 1, Page 1-41, 2013.
Vivian Welch   +9 more
wiley   +1 more source

Drug trials for treatment of human angiostrongyliasis [PDF]

open access: yes, 2003
Abdominal and cerebral angiostrongyliasis are two important infections produced by metastrongylid worms, the former occurring in Central and South America and the later in Asia and Pacific Islands.
Graeff-Teixeira, Carlos   +1 more
core   +4 more sources

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. [PDF]

open access: yes, 2000
We examined the long-term efficacy of praziquantel against Schistosoma haematobium, the causative agent of urinary schistosomiasis, during a school-based treatment program in the Msambweni area of Coast Province, Kenya, where the disease is highly ...
King, C. H., Muchiri, E. M., Ouma, J. H.
core   +2 more sources

La lutte contre les schistosomoses en Afrique de l'Ouest [PDF]

open access: yes, 2000
Créé en 1980, le Cermes a effectué de nombreuses recherches appliquées et opérationnelles dans le domaine des schistosomoses, au Niger principalement, mais aussi dans l'ensemble des pays de l'OCCGE.
Chippaux, Jean-Philippe
core  

Evaluation of the schistosomicidal efficacy of liposome - Entrapped Oxamniquine [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1997
Oxamniquine (OXA) was sucessfully encapsulated in small unilamellar vesicles using a pH gradient method. This procedure led to a high drug encapsulation efficiency (> 85%) at a drug to lipid molar ratio of 1/10. Moreover, these liposomes were found to retain encapsulated OXA efficciently under dialysis conditions at 37º C.
Alan Lane de Melo, Frédéric Frézard
openaire   +4 more sources

Revisiting the SAR of the antischistosomal aryl hydantoin (Ro 13-3978) [PDF]

open access: yes, 2016
The aryl hydantoin 1 (Ro 13-3978) was identified in the early 1980s as a promising antischistosomal lead compound. However, this series of aryl hydantoins produced antiandrogenic side effects in the host, a not unexpected outcome given their close ...
Charman, Susan A.   +13 more
core   +3 more sources

Occupational Health Risk Factors for Schistosomiasis: Systematic Review and Analysis [PDF]

open access: yes, 2015
Schistosomiasis is a neglected tropical disease caused by a parasitic flatworm which afflicts over 200 million people in the poorest regions of Africa.
Butera, Gisela   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy